| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |